Le Stunff C, Rotwein P
Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Endocrinology. 1998 Mar;139(3):859-66. doi: 10.1210/endo.139.3.5819.
Interferon regulatory factor-1 (IRF-1) is a transcription factor first identified as part of the nuclear response to interferons. IRF-1 has been shown to be activated by many cytokines, including PRL, and has been thought to play a role in PRL-regulated gene expression in several experimental systems, including the Nb2 T lymphoma cell line, where it was first characterized as a PRL-responsive gene. We now find that IRF-1 gene expression is rapidly activated in vivo by both PRL and GH treatment. A single i.p. injection of rat PRL to hypophysectomized female rats caused a transient increase in nascent hepatic nuclear IRF-1 RNA within 15 min of hormone treatment. The rise in IRF-1 transcripts was accompanied by induction of nuclear protein binding to a DNA element from the proximal IRF-1 promoter, as assessed by gel mobility shift assays; this element was shown previously to mediate PRL-activated gene transcription. GH treatment stimulated a greater and more sustained increase in nascent IRF-1 RNA than PRL, leading to accumulation of IRF-1 transcripts for up to 16 h after a single hormone injection. GH also caused a pronounced induction of hepatic nuclear protein binding to the IRF-1 promoter element. Supershift experiments with specific antibodies showed that signal transducer and activator of transcription 1 (STAT1) and to a lesser extent STAT3 were components of the GH-activated protein-DNA complexes. By contrast, these two STATs were not induced in the liver by PRL. Protein binding to the IRF-1 DNA element and IRF-1 gene activation by GH were not blunted by pretreatment with the protein synthesis inhibitor, cycloheximide, indicating that these hormonal effects are primary consequences of GH-activated signal transduction pathways. Our results identify another component of the rapid nuclear response to GH, and support the idea that multiple primary and secondary signaling pathways contribute to the acute actions of GH on gene expression.
干扰素调节因子-1(IRF-1)是一种转录因子,最初被鉴定为细胞核对干扰素反应的一部分。IRF-1已被证明可被多种细胞因子激活,包括催乳素(PRL),并且在包括Nb2 T淋巴瘤细胞系在内的多个实验系统中,被认为在PRL调节的基因表达中发挥作用,在该细胞系中它最初被表征为一个PRL反应基因。我们现在发现,PRL和生长激素(GH)处理均可在体内迅速激活IRF-1基因表达。对垂体切除的雌性大鼠单次腹腔注射大鼠PRL,在激素处理后15分钟内可使新生肝细胞核IRF-1 RNA短暂增加。IRF-1转录本的增加伴随着通过凝胶迁移率变动分析评估的与IRF-1近端启动子的DNA元件结合的核蛋白的诱导;先前已证明该元件介导PRL激活的基因转录。与PRL相比,GH处理刺激新生IRF-1 RNA的增加更大且更持久,导致在单次激素注射后长达16小时内IRF-1转录本积累。GH还显著诱导肝细胞核蛋白与IRF-1启动子元件结合。用特异性抗体进行的超迁移实验表明,信号转导子和转录激活子1(STAT1)以及程度较轻的STAT3是GH激活的蛋白质-DNA复合物的组成成分。相比之下,这两种STAT在肝脏中不会被PRL诱导。蛋白质与IRF-1 DNA元件的结合以及GH对IRF-1基因的激活不会因用蛋白质合成抑制剂环己酰亚胺预处理而减弱,这表明这些激素效应是GH激活的信号转导途径的主要后果。我们的结果确定了GH快速核反应的另一个组成部分,并支持多种初级和次级信号通路有助于GH对基因表达的急性作用这一观点。